May 20, 2020 / 11:43 AM / 13 days ago

BRIEF-Zentalis Pharma Announces $20 Mln Series A Financing To Establish A Chinese Joint Venture, Zentera Therapeutics

May 20 (Reuters) - Zentalis Pharmaceuticals Inc:

* ZENTALIS PHARMACEUTICALS ANNOUNCES $20 MILLION SERIES A FINANCING TO ESTABLISH A CHINESE JOINT VENTURE, ZENTERA THERAPEUTICS

* ZENTALIS PHARMACEUTICALS - PROCEEDS FROM FINANCING WILL BE USED TO DEVELOP, COMMERCIALIZE 3 CANCER THERAPIES DISCOVERED BY CO

* ZENTALIS PHARMACEUTICALS INC - PROCEEDS FROM SERIES A FINANCING WILL BE USED TO DEVELOP AND COMMERCIALIZE POTENTIAL FUTURE CANDIDATES IN CHINA

* ZENTALIS PHARMACEUTICALS INC - ANTHONY SUN, MD, CEO OF ZENTALIS, WILL SERVE AS CEO OF ZENTERA Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below